CELG Short Information, Celgene Corporation

Twenty Trading Day Totals
Total Shorted Volume	3,068,787
Total Actual Volume	72,901,978

Averages
Average Short Volume	153,439
Average Short Percentage	30.82%

Is there a CELG Short Squeeze or Breakout about to happen?

See the CELG Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2019-10-17	101.11	101.86	102.02	101.11	2,053,419	162,691	29.1552
2019-10-16	100.64	100.97	101.22	100.50	3,221,244	118,859	17.3910
2019-10-15	100.50	100.95	101.185	100.40	2,655,352	164,635	39.9255
2019-10-14	100.53	100.39	100.66	100.1111	1,836,076	99,496	31.3140
2019-10-11	100.25	100.57	100.96	99.98	3,698,436	120,937	41.5115
2019-10-10	99.73	99.81	99.90	99.26	3,238,951	126,690	49.3872
2019-10-09	99.04	99.63	99.86	99.03	2,979,581	69,232	22.1011
2019-10-08	99.25	98.88	100.02	98.67	4,213,530	95,751	16.9142
2019-10-07	99.63	99.70	100.42	99.56	3,627,720	121,189	34.6289
2019-10-04	98.51	99.87	100.10	98.43	3,469,435	165,005	45.9405
2019-10-03	97.51	98.42	98.43	97.34	3,784,489	79,692	35.5657
2019-10-02	98.97	97.62	98.98	97.30	4,375,627	198,299	24.8030
2019-10-01	99.51	99.26	100.19	99.05	4,202,619	175,362	31.4564
2019-09-30	98.85	99.30	99.93	98.53	5,198,727	343,576	25.2374
2019-09-27	98.68	98.85	99.25	98.44	4,643,178	231,071	30.6895
2019-09-26	98.58	98.59	98.88	97.97	3,763,368	81,392	12.0852
2019-09-25	98.62	98.56	99.05	98.37	2,900,832	73,582	22.1784
2019-09-24	99.80	98.62	99.85	98.48	4,523,337	178,996	28.2802
2019-09-23	99.45	99.42	99.81	99.31	3,128,528	268,317	45.0917
2019-09-20	98.65	99.37	99.66	98.50	5,387,529	194,015	32.7901

Stock Information

Celgene Corporation Company Name:

CELG Stock Symbol:

NASDAQ Market:

Celgene Corporation Website:

CELG Short Information, Celgene Corporation

Get CELG Alerts

News, Short Squeeze, Breakout and More Instantly...

CELG - Inside Gilead's Lackluster $7.2 Billion Q4 Earnings

In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
CELG - Amgen Blows Past EPS Estimates for the Second Quarter

What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
CELG - 3 Healthcare Stocks With a Solid Bottom Line -- and a Dividend

It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...